This publication spans multiple updates regarding systemic treatment for patients with myelofibrosis, as well as expert insights in video format covering how they approach their patients with newly available agents.
Nuanced Approaches Needed to Adequately Manage Symptoms, Guide Care in Myelofibrosis
Raajit K. Rampal, MD, PhD, discusses symptom management in patients with myelofibrosis, defining disease progression, and key considerations for starting or delaying treatment.
Spotlighting Symptom Management Strategies, Factors to Inform Treatment Decisions in Myelofibrosis
Naveen Pemmaraju, MD, discusses approaches to adequately manage symptoms experienced by patients with myelofibrosis, challenges faced with defining disease progression, and strategies for when to initiate or delay treatment.
Dr. Pemmaraju on Characteristics of Disease Progression in Myelofibrosis
Naveen Pemmaraju, MD, discusses the characteristics of disease progression in patients with myelofibrosis.
Dr. Mauro on Managing Symptom Burden in Myelofibrosis
Michael J. Mauro, MD, discusses managing symptom burden in patients with myelofibrosis.
Dr Phillips on the Treatment Landscape for Patients With MCL
Dr Chari on the Bridging the Gaps in Hematologic Malignancies Meeting
Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies
Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL
2 Commerce Drive Cranbury, NJ 08512